Technological change in the pharmaceutical industry: policies for technology transfer and management for the developing countries Online publication date: Tue, 19-Feb-2008
by Jarunee Wonglimpiyarat
International Journal of Technology, Policy and Management (IJTPM), Vol. 8, No. 2, 2008
Abstract: This paper analyses the technological change in the pharmaceutical industry. Drawing on Schumpeter's long waves theory, it is argued that the technological change in the pharmaceutical industry is evolutionary and a de-maturity process. The development of genomic technologies has opened up opportunities for using molecular diagnostics to improve the quality of healthcare and human life. Currently, the high cost of Research and Development (R&D) investment has shifted the big pharmaceutical companies from the development of drugs based on antibacterial research towards drugs for chronic diseases because the latter are commercially viable. The paper proposes a model of technology transfer to correct the imbalance between a decreasing supply of and a growing demand for drugs for diseases in the developing countries. The paper offers policy recommendations to resolve the problems of deficient drug development in the developing countries.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology, Policy and Management (IJTPM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook